XML 12 R2.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 132,627 $ 91,954
Short-term investments 133,807 178,917
Accounts receivable, net [1] 45,905 48,296
Prepaid expenses and other assets 12,404 10,632
Total current assets 324,743 329,799
Property and equipment, net 18,653 12,863
Intangible assets, net 91,840 98,921
Operating lease right-of-use assets 24,093 24,729
Goodwill 107,822 107,822
Other assets 4,068 3,606
Total assets 571,219 577,740
Current liabilities:    
Accounts payable 4,626 5,332
Accrued liabilities 12,946 16,510
Deferred revenue [1] 51,634 47,145
Operating lease liabilities 2,454 2,622
Contingent consideration liabilities 15,902 14,427
Acquisition-related consideration payable [1] 0 2,000
Convertible senior notes, net 171,864 0
Total current liabilities 259,426 88,036
Convertible senior notes, net of current portion 0 168,994
Deferred revenue, net of current portion 1,135 1,878
Operating lease liabilities, net of current portion 23,083 23,669
Contingent consideration liabilities, net of current portion 16,509 16,837
Other liabilities 2,230 2,227
Total liabilities 302,383 301,641
Commitments and contingencies (Note 14)
Stockholders’ equity:    
Preferred stock, $0.001 par value per share; 25,000,000 shares authorized as of March 31, 2021 and December 31, 2020; no shares issued and outstanding as of March 31, 2021 and December 31, 2020 0 0
Common stock, $0.001 par value per share; 500,000,000 shares authorized as of March 31, 2021 and December 31, 2020; 44,340,036 and 43,376,848 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively 44 43
Additional paid-in capital 1,022,781 1,001,645
Accumulated deficit (754,020) (725,650)
Accumulated other comprehensive income 31 61
Total stockholders’ equity 268,836 276,099
Total liabilities and stockholders’ equity $ 571,219 $ 577,740
[1] Includes amounts attributable to related party transactions. See Note 16 for further details.